Skip to main content
Caplight Logo









NX Prenatal Inc.

NX Prenatal Inc.

Private
Bellaire, TexasHealthcare & Life Scienceshttps://www.nxprenatal.com/

Last Round

Series A

Aug 21, 2023

Total Funding Raised

$6M

Company Overview

NX Prenatal Inc. is a molecular diagnostics company that develops exosome-based diagnostic assays for the detection and management of pregnancy-related complications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

liquid biopsymolecular diagnosticsexosome diagnosticsprenatal screeningpreterm birth riskbiomarker discoveryprecision medicineproteomicsclinical diagnosticspredictive diagnosticspregnancy complicationsnon-invasive testingAI diagnosticsfemtechmaternal health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NX Prenatal Inc. Comparables

Compare NX Prenatal Inc. with similar companies based on industry and business-model similarity.

NX Prenatal Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Milu Labs
88%
Mirvie
80%
Sera Prognostics Inc.
79%

NX Prenatal Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 21, 2023
VC RoundMay 26, 2021
VC RoundMay 2, 2018
VC RoundMay 27, 2016
VC RoundJan 29, 2014
VC Round
Jan 26, 2011

NX Prenatal Inc. Investors

Notable investors and investment history

NX Prenatal Inc. investors
InvestorRounds
The JumpFundSeries A
Mindshift CapitalSeries A
Keyhorse CapitalVC Round, Series A
VisionTech PartnersVC Round, Series A
Commonwealth Capital VenturesSeries A
XLerateHealthVC Round
Golden SeedsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 22, 2026

    Monthly visitors grew 15,750% MoM, from 8 to 1.3K.

  • Aug 21, 2023

    $6M round led by Solas BioVentures.

NX Prenatal Inc. Filings

Explore SEC and related filing metadata, where available.

NX Prenatal Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about NX Prenatal Inc.'s valuation, stock price, and market status.

Is NX Prenatal Inc. a public or private company?

NX Prenatal Inc. is a private company.

What is the current stock price of NX Prenatal Inc.?

NX Prenatal Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is NX Prenatal Inc. worth (valuation)?

Valuation information for NX Prenatal Inc. is not publicly available.

Can I buy NX Prenatal Inc. stock?

NX Prenatal Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was NX Prenatal Inc.'s last funding round?

NX Prenatal Inc.'s most recent funding round was Series A on August 21, 2023.

Who are the main investors in NX Prenatal Inc.?

Key investors in NX Prenatal Inc. include Solas BioVentures.

Will NX Prenatal Inc. IPO soon?

No public IPO plans have been announced for NX Prenatal Inc..

How can I track NX Prenatal Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NX Prenatal Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBellaire, Texas
Employee Range2
Year FoundedN/A
Last FundingAug 21, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?